Karen Hofman
University of the Witwatersrand
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Karen Hofman.
American Journal of Public Health | 1993
Ellen S. Tambor; Gary A. Chase; Ruth R. Faden; Gail Geller; Karen Hofman; Neil A. Holtzman
OBJECTIVES This study assessed efforts to increase response rates to a mailed physician survey and examined whether, as a result, nonresponse bias was reduced. METHODS Randomly selected physicians and geneticists were mailed a questionnaire concerning genetics knowledge and attitudes. In the final but not the pilot survey, a
BMC Public Health | 2013
Maria Cabrera Escobar; J. Lennert Veerman; Stephen Tollman; Melanie Bertram; Karen Hofman
25 incentive and intensive follow-up were used to increase the response rate. RESULTS The response rate from physicians in the final survey was 64.8% (n = 1140), compared with 19.6% in the pilot test (n = 69). Sample representatives in sociodemographic and practice characteristics was improved by follow-up. Respondents recruited with more difficulty did not differ on the principal outcome variable, genetics knowledge, except on one subscore. Pilot study and final survey respondents did not differ in knowledge. CONCLUSIONS Although the effect of increased response rates on the principal outcome variable in this study was minimal, this may not be the case for other studies. Every effort should be made to attain as high a response rate as is practical and to establish that respondents are representative of the population being sampled.
American Journal of Medical Genetics | 1996
Martha B. Denckla; Karen Hofman; M. Mazzocco; E. Melhem; Allan L. Reiss; R. N. Bryan; Emily L. Harris; J. Lee; C. S. Cox; Linda J. Schuerholz
BackgroundExcess intake of sugar sweetened beverages (SSBs) has been shown to result in weight gain. To address the growing epidemic of obesity, one option is to combine programmes that target individual behaviour change with a fiscal policy such as excise tax on SSBs. This study evaluates the literature on SSB taxes or price increases, and their potential impact on consumption levels, obesity, overweight and body mass index (BMI). The possibility of switching to alternative drinks is also considered.MethodsThe following databases were used: Pubmed/Medline, The Cochrane Database of Systematic Reviews, Google Scholar, Econlit, National Bureau of Economics Research (NBER), Research Papers in Economics (RePEc). Articles published between January 2000 and January 2013, which reported changes in diet or BMI, overweight and/or obesity due to a tax on, or price change of, SSBs were included.ResultsNine articles met the criteria for the meta-analysis. Six were from the USA and one each from Mexico, Brazil and France. All showed negative own-price elasticity, which means that higher prices are associated with a lower demand for SSBs. Pooled own price-elasticity was -1.299 (95% CI: -1.089 - -1.509). Four articles reported cross-price elasticities, three from the USA and one from Mexico; higher prices for SSBs were associated with an increased demand for alternative beverages such as fruit juice (0.388, 95% CI: 0.009 – 0.767) and milk (0.129, 95% CI: -0.085 – 0.342), and a reduced demand for diet drinks (-0.423, 95% CI: -0.628 - -1.219). Six articles from the USA showed that a higher price could also lead to a decrease in BMI, and decrease the prevalence of overweight and obesity.ConclusionsTaxing SSBs may reduce obesity. Future research should estimate price elasticities in low- and middle-income countries and identify potential health gains and the wider impact on jobs, monetary savings to the health sector, implementation costs and government revenue. Context-specific cost-effectiveness studies would allow policy makers to weigh these factors.
The Lancet | 2017
Felicia Marie Knaul; Paul Farmer; Eric L. Krakauer; Liliana De Lima; Afsan Bhadelia; Xiaoxiao Jiang Kwete; Héctor Arreola-Ornelas; Octavio Gómez-Dantés; Natalia M. Rodriguez; George Alleyne; Stephen R Connor; David J. Hunter; Diederik Lohman; Lukas Radbruch; María del Rocío Sáenz Madrigal; Rifat Atun; Kathleen M. Foley; Julio Frenk; Dean T. Jamison; M R Rajagopal; Huda Abu-Saad Huijer; Agnes Binagwaho; Snežana M Bošnjak; David M. Clark; James F. Cleary; José R Cossío Díaz; Cynthia Goh; Pascal J. Goldschmidt-Clermont; Mary Gospodarowicz; Liz Gwyther
To address the controversy regarding the relationship between cognitive impairment (lowering of IQ) and magnetic resonance imaging (MRI) characteristics (T2-weighted hyperintensities or unidentified bright objects [UBOs]) in children with neurofibromatosis-1 (NF-1), we used a pairwise NF-1/ sibling design; we set out to predict the lowering of IQ in each child with NF-1 as a discrepancy from the IQ of an unaffected sibling (D-SIQ). Our multiple regression model included the age of the child with NF-1, familial or sporadic nature of the NF-1, number of locations in the childs brain occupied by T2-weighted hyperintensities (UBOs), and the volumetric percentage of brain tissue occupied by T2-weighted hyperintensities (UBOs). Only the number of locations occupied by UBOs accounted for IQ lowering (D-SIQ) in children with NF-1 (42% of the variance in D-SIQ). This is the first report to confirm that a continuum of lowered IQs in NF-1-affected children exists in relation to the distribution of UBOs (range 0-7), not just presence (vs. absence) of any UBOs.
Diabetes Research and Clinical Practice | 2013
Taskeen Khan; Melanie Bertram; Ruxana Jina; Bob Mash; Naomi S. Levitt; Karen Hofman
Felicia Marie Knaul, Paul E Farmer*, Eric L Krakauer*, Liliana De Lima, Afsan Bhadelia, Xiaoxiao Jiang Kwete, Héctor Arreola-Ornelas, Octavio Gómez-Dantés, Natalia M Rodriguez, George A O Alleyne, Stephen R Connor, David J Hunter, Diederik Lohman, Lukas Radbruch, María del Rocío Sáenz Madrigal, Rifat Atun†, Kathleen M Foley†, Julio Frenk†, Dean T Jamison†, M R Rajagopal†, on behalf of the Lancet Commission on Palliative Care and Pain Relief Study Group‡
Health Policy and Planning | 2014
Hadley K.H. Wesson; Nonkululeko Boikhutso; Abdulgafoor M Bachani; Karen Hofman; Adnan A. Hyder
BACKGROUND South Africa like many other developing countries is experiencing an epidemiologic transition with a marked increase in the non-communicable disease (NCD) burden. Diabetic retinopathy is the most common cause of incidental blindness in adults. A screening programme using a mobile fundal camera in a primary care setting has been shown to be effective in the country. Information on affordability and cost is essential for policymakers to consider its adoption. METHODS Economic evaluation is the comparative analysis of competing alternative interventions in terms of costs and consequences. A cost effectiveness analysis was done using actual costs from the primary care screening programme. RESULTS A total of 14,541 patients were screened in three primary healthcare facilities in the Western Cape. Photographs were taken by a trained technician with supervision by an ophthalmic nurse. The photographs were then read by a medical officer with ophthalmic experience. A cost effective ratio of
Global Health Action | 2013
Melanie Bertram; Aneil V.S. Jaswal; Victoria Pillay Van Wyk; Naomi S. Levitt; Karen Hofman
1206 per blindness case averted was obtained. This included costs for screening and treating an individual. The cost just to screen a patient for retinopathy was
PLOS ONE | 2014
Mercy Manyema; Lennert Veerman; Lumbwe Chola; Aviva Tugendhaft; Benn Sartorius; Demetre Labadarios; Karen Hofman
22. The costs of screening and treating all incident cases of blindness due to diabetes in South Africa would be 168,000,000 ZAR (
PLOS ONE | 2015
Benn Sartorius; Lennert Veerman; Mercy Manyema; Lumbwe Chola; Karen Hofman
19,310,344) per annum. CONCLUSION Non mydriatic digital fundoscopy is a cost effective measure in the screening and diagnosis of diabetic retinopathy in a primary care setting in South Africa. The major savings in the long term are a result of avoiding government disability grant for people who suffer loss of vision.
Global Health Action | 2013
Karen Hofman; Yulia Blomstedt; Sheila Addei; Rose Kalage; Mandy Maredza; Osman Sankoh; Martin Bangha; Kathleen Kahn; Heiko Becher; Joke A. Haafkens; John Kinsman
INTRODUCTION Injuries are a significant cause of mortality and morbidity, of which more than 90% occur in low- and middle-income countries (LMICs). Given the extent of this burden being confronted by LMICs, there is need to place injury prevention at the forefront of public health initiatives and to understand the costs associated with injury. The aim of this article is to describe the extent to which injury-related costing studies have been conducted in LMICs. METHODS A review of literature was performed to explore costing data available for injury and/or trauma care in LMICs. Study quality was described using recommendations from the Community Guides quality assessment tool for economic evaluations. RESULTS The review identified 68 studies, of which 13 were full economic evaluations. Cost of injury varied widely with mean costs ranging from US